Register or Sign in
to unlock feature

you are not authorized to read this article.

Login or register your account to get full access to the tableting technology platform.

Login Register
Please verify your account
Please confirm your email address to validate your registration. Follow the link on email received to verify your email adress.
Re-send verification email
Please complete your registration
You're logged in but you didn't complete your registration.
Complete my registration
Exclusive content

You are not authorized to read this article.

mystylone subscription is required to view this content.

Login Register
Close search
  • Resources
  • Products & Services
    • Compaction Simulators
    • R&D / Process Support
  • Events
  • About
  • Contact Us
  • Sign in
Resources
  1. Home /
  2. Resources /
  3. Newsfeeds /
  4. Optimizing API load and minimizing tablet weight leveraging an innovative DC Mannitol
NEWSFEEDS

Optimizing API load and minimizing tablet weight leveraging an innovative DC Mannitol

June 26, 2024
Remove from favorites
Add to favorites

*INTRODUCTION

Tablets with stability issues often utilize mannitol, a stable, water-soluble excipient. Direct compression is a preferred method for its simplicity and cost-effectiveness. However, directly compressible mannitol grades tend to cap under high tableting speeds or compression forces. Solutions to capping, such as precompression, reduced production speed, or lower compression force, usually require reducing the API load.

*OBJECTIVES

PEARLITOL® 200 GT is a granulated beta mannitol designed for direct compression, optimized to improve tabletability and reduce capping. Its high powder density enhances tabletability and prevents capping, allowing for increased API load and smaller tablet size for the same dosage. The study used sertraline, a poorly tabletable API, to test these improvements against a reference spray-dried mannitol (PEARLITOL® 200 SD).

*MATERIALS AND METHODS

Materials included granulated mannitol (PEARLITOL® 200 GT), spray-dried mannitol (PEARLITOL® 200 SD), magnesium stearate, and sertraline. Mannitol and sertraline were mixed, with magnesium stearate added subsequently. Powder properties such as bulk density, tapped density, Hausner ratio, flow time, and angle of repose were measured. All tableting trials were done on a high-speed rotary tablet press simulator STYLCAM 200R (MEDELPHARM) using KORSCH XL 400 profile.

*RESULTS

Sertraline powder had poor flow properties. Blends with PEARLITOL® 200 SD were free-flowing up to 15% sertraline. Blends with PEARLITOL® 200 GT were free-flowing up to 25%, allowing tablet production up to 40% sertraline. Without precompression, PEARLITOL® 200 SD exhibited capping at all sertraline ratios, while PEARLITOL® 200 GT did not cap up to 25% sertraline. With precompression, PEARLITOL® 200 GT produced viable tablets up to 40% sertraline, while PEARLITOL® 200 SD capped at 15% sertraline.

*CONCLUSION

Using PEARLITOL® 200 GT for direct compression significantly improves tabletability, allowing for higher API loads or smaller tablets. PEARLITOL® 200 GT enabled up to a 166% increase in API load or a 62% reduction in tablet weight compared to PEARLITOL® 200 SD.

Read more
Image study - benefits of an optimal tabletability DC Mannitol on compression-resize
Tablet hardness vs compression force at increasing sertraline ratio without procompression force
manufacturing tablet
Contributor(s):
Share Copied!
Comments

No comments posted yet.

Add a comment

Articles you may like

no-image

QbD approach formulation design for metformin HCI and evaluations

first_published_at:Jan. 1, 2019, midnight / date_published:Jan. 1, 2019
Papers - 01/01/2019 - by Omar Hourani
This study aimed to formulate Metformin HCI 500 mg tablets using the Direct Compression (DC) method, selecting appropriate excipients, and evaluating the formulation outcomes. In order to achieve an optimized …

Production challenges of tablets containing lipid excipients: case study using cannabidiol as drug model

Production challenges of tablets containing lipid excipients: case study using cannabidiol as drug model

first_published_at:Jan. 21, 2023, midnight / date_published:Jan. 21, 2023
Papers - 21/01/2023 - by Koch Nathan, Jennotte Olivier, Toussaint Céline, Lechanteur Anna, Evrard Brigitte
This study pursued dual objectives. Firstly, it sought to identify the most effective lipid solid dispersion for cannabidiol from a range of lipid excipients (Gelucire® 50/13, 48/16, 44/14, and Labrasol®) …

no-image

Production challenges of tablets containing lipid excipients: Case study using cannabidiol as drug model

first_published_at:Feb. 25, 2023, midnight / date_published:Feb. 25, 2023
Papers - 25/02/2023 -
The aims of this study were, firstly, to select an optimal lipid solid dispersion of cannabidiol among different lipid excipients (Gelucire® 50/13, 48/16, 44/14 and Labrasol®) and inorganic carriers (colloidal …

More

Related products

Accessory_Evo_instrumented_die_2

Radial Pressure Instrumented Die - STYL'One Evo

MEDELPHARM
The axial stress impulsed by punches during powder compression induces a horizontal response called die …
Accessory_Nano_instrumented_die_4

Radial Pressure Instrumented Die - STYL'One Nano

MEDELPHARM
The axial stress impulsed by punches during powder compression induces a horizontal response called die …
illustration STYL'One Mist manual lubrication

Manual External Lubrication

MEDELPHARM
In development, external lubrication enables the characterization of the compaction behavior of pure APIs or …
ME-S2-300-091

Automatic External Lubrication

MEDELPHARM
In development, external lubrication enables the characterization of the compaction behavior of pure APIs or …
material characterization

Material Characterization

Understand powder behavior to develop robust formulations. API characterization, excipient selection, and manufacturing process determination …
STYL'One Nano scientist powder zoom

On-site Training Program - STYL'One Nano

This 1-day program, conducted in your laboratory, incorporates classroom concepts, hands-on instruction, and interactive workshops …
tablet formulation development

Tablet Formulation Development

Understand powder behavior to develop robust formulations. API characterization, excipient selection, and manufacturing process determination …
scale-up support

Scale-up Support

Transfer R&D findings to production. Successful scale-up is key for tablet manufacturing efficiency. De-risk scale-up …
process optimization

Process Optimization

Successful process optimization is key for tablet manufacturing efficiency. Optimize your production process parameters with …
process troubleshooting

Process Troubleshooting

Successful troubleshooting is key for tablet manufacturing efficiency. Adjusting process parameters (compression speed, edge thickness, …
laptop laboratory gloves

Looking for additional information?

Let us help you

Contact our experts

GENERAL

  • Terms of service
  • Privacy Policy
  • Cookie Policy
  • About
  • Contact us

Account

  • Login

Follow us on

© 2025 Medelpharm